{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:24:58Z","timestamp":1795040698633,"version":"4.10.2"},"reference-count":49,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["mAbs"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/19420862.2023.2261509","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T09:08:58Z","timestamp":1697101738000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":178,"title":["Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans"],"prefix":"10.1080","volume":"15","author":[{"given":"Hans Peter","family":"Grimm","sequence":"first","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Imhof-Jung","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Ola","family":"Freskg\u00e5rd","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Brady","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"R\u00fcger","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Schlothauer","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"G\u00f6pfert","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Hartl","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Rottach","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Zwick","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanon","family":"Seger","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Neff","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Niewoehner","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Janssen","sequence":"additional","affiliation":[{"name":"Roche Innovation Center Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"e_1_3_5_2_1","first-page":"007","article-title":"Is beta-amyloid accumulation a cause or consequence of Alzheimer\u2019s disease?","volume":"1","author":"Wang S","year":"2016","unstructured":"Wang S, Mims PN, Roman RJ, Fan F. Is beta-amyloid accumulation a cause or consequence of Alzheimer\u2019s disease? J Alzheimers Parkinsonism Dement. 2016;1:007.","journal-title":"J Alzheimers Parkinsonism Dement"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12328"},{"key":"e_1_3_5_4_1","unstructured":"US Food and Drug Administration (FDA). FDA\u2019s decision to approve new treatment for Alzheimer\u2019s disease [press release]; 2021 June 7 [accessed 2023 June 28]. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fdas-decision-approve-new-treatment-alzheimers-disease."},{"key":"e_1_3_5_5_1","unstructured":"US Food and Drug Administration (FDA). FDA grants accelerated approval for Alzheimer\u2019s disease treatment [press release]; 2023 January 6 [accessed 2023 June 28]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-alzheimers-disease-treatment."},{"key":"e_1_3_5_6_1","unstructured":"Aging NNIo. NIA statement on report of lecanemab reducing cognitive decline in Alzheimer\u2019s clinical trial; 2023 [accessed 2023 March 16]. https:\/\/www.nia.nih.gov\/news\/nia-statement-report-lecanemab-reducing-cognitive-decline-alzheimers-clinical-trial"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180903"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520907397"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110977"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00404"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-8-8"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9343514"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.126"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.03.014"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101665"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016244500596"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17740031"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.11.024"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009835"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b01166"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.01.009"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12081"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005338"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.10.061"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.12.019"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0559-z"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S53401"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.1538"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2020.68"},{"key":"e_1_3_5_32_1","first-page":"S10","article-title":"Topline results of phase III GRADUATE I & II pivotal trials with subcutaneous gantenerumab","volume":"9","author":"Bateman R","year":"2022","unstructured":"Bateman R, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, et al. Topline results of phase III GRADUATE I & II pivotal trials with subcutaneous gantenerumab. J Prev Alzheimers Dis. 2022;9:S10.","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_3_5_33_1","unstructured":"Ltd. FH-LR. [Ad Hoc Announcement Pursuant To Art. 53 LR] Roche Provides Update On Phase III GRADUATE Programme Evaluating Gantenerumab In Early Alzheimer\u2019s Disease. 2022 [accessed 2023 March 16]. https:\/\/www.roche.com\/media\/releases\/med-cor-2022-11-14."},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12379"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2535"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.3.1.13799"},{"key":"e_1_3_5_37_1","unstructured":"ICH S6 (R1) Preclinical safety evaluation of biotechnology-derived pharmaceuticals. International Council For Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use (ICH); 1997 [accessed 2023 14\/08\/2023]. https:\/\/www.ich.org\/."},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzw040"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1359"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1171315"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.209130"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1473910"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.055"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep25658"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1457"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.09.004"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229850"},{"key":"e_1_3_5_48_1","volume-title":"Ver. 4.3.3 [software]","author":"Monolix","year":"2014","unstructured":"Monolix. Ver. 4.3.3 [software]. Antony (France): Lixoft; 2014 September."},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1952"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0146-6453(03)00002-2"}],"container-title":["mAbs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/19420862.2023.2261509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:14:08Z","timestamp":1753258448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19420862.2023.2261509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/19420862.2023.2261509"],"URL":"https:\/\/doi.org\/10.1080\/19420862.2023.2261509","relation":{},"ISSN":["1942-0862","1942-0870"],"issn-type":[{"value":"1942-0862","type":"print"},{"value":"1942-0870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2261509"}}